ACS Combinatorial Science 2018-03-02

A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts

I. Ayelen Ramallo, Victoria L. Alonso, Federico Rua, Esteban Serra, Ricardo L. E. Furlan

Index: 10.1021/acscombsci.7b00172

Full Text: HTML

Abstract

A set of chemically engineered extracts enriched in compounds including N–N and N–O fragments in their structures was prepared. Bromodomain binding screening and bioguided fractionation led to the identification of one oxime hit that interacts with TcBDF3 with affinity in the submicromolar range and that shows interesting antiparasitic properties against the different life cycle stages of T. cruzi.

Latest Articles:

A Parallel Approach to 7-(Hetero)arylpyrazolo[1,5-a]pyrimidin-5-ones

2018-04-06

[10.1021/acscombsci.8b00032]

Solid-Phase Synthesis of β-Hydroxy Ketones Via DNA-Compatible Organocatalytic Aldol Reactions

2018-04-03

[10.1021/acscombsci.8b00001]

Construction of Druglike 2-Amido Benzo[d]imidazole Analogues via Desulfurative Cyclization of Thiourea Intermediate Resin on Solid-Phase

2018-03-26

[10.1021/acscombsci.8b00004]

Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators

2018-03-23

[10.1021/acscombsci.7b00193]

A General Small-Angle X-ray Scattering-Based Screening Protocol Validated for Protein–RNA Interactions

2018-03-23

[10.1021/acscombsci.8b00007]

More Articles...